The purpose of this study is to determine the effectiveness of Paclitaxel and Ipatasertib in patients who progressed within 6 months of taxane-based therapy. You must have a a AKT-Altered cancer. You must have a locally advanced, unresectable or metastatic cancer.
Contact phoneTera Williams | 517.364.2910
Principal investigatorDr. Gordan Srkalovic, MD, PhD
Trial SubCategorySolid Tumors (non-breast)